SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,640.00    -10.00 (-0.18%)
Bid:
5,640.00
Ask:
5,670.00
Spread: 30.00 (0.532%)
Market Cap: £3.02b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Q3 Interim Management Statement

30 Jan 2012 07:00

RNS Number : 3506W
Cranswick PLC
30 January 2012
 



30 January 2012

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

Third quarter interim management statement

 

Cranswick, the UK food producer, today provides an update on trading for the period from 1 October 2011 to 29 January 2012.

 

Current trading

 

The Company benefited from a strong sales performance in the three months to 31 December 2011.

 

Sales for the quarter increased by 10 per cent on the same period last year, building on the momentum established in the first half. Sales growth in the quarter of bacon and fresh pork products was particularly strong and there were positive contributions from all other categories. Export sales remained buoyant and sales of pastry products continued to show pleasing progress.

 

As previously reported, pig meat products continue to gain an increased share of the UK retail protein market. Recent market data highlighted a further acceleration in this gain over the Christmas trading period. Both the versatility and the low relative price of pork to other proteins are key to this positive trend. The growing popularity of pork products continues to be a contributory factor in the increase in sales at Cranswick.

 

There was some recovery in operating margin in the third quarter from that reported in the first half, although for the year to date it remains below that achieved in the comparable period last year.

 

Financial position

 

Following the expected seasonal increase in working capital, the substantial uplift in sales and on-going capital expenditure, net debt increased from £48 million to £59 million during the quarter. The operating cash outflow in the period was in line with last year. The Group is in a strong financial position, with committed, unsecured facilities of £100 million which provide generous headroom going forward.

 

Outlook

 

The business has a well invested asset base, loyal and skilled teams, a great range of products and a strong financial position. Good progress has been made following the challenges of the first half and the Board looks forward positively to the rest of the year and the long term development of Cranswick.

 

Enquiries:

 

CityRoad Communications +44 (0) 20 7248 8010

Paul Quade +44 (0) 7947 186 694

 

 

Notes:

1. Cranswick's activities are focused within the UK and include the processing and supply of fresh pork, sausage, bacon, cooked meats, charcuterie, pastry products and sandwiches. Products are primarily supplied into the UK food retail, food service and food manufacturing sectors. Results for the year to 31 March 2011 showed sales of £758m and profit before tax of £47.1m.

2. This announcement is based on information sourced from unaudited management accounts.

3. This announcement represents Cranswick's third quarter Interim Management Statement for the period from 1 October 2011 to 29 January 2012.

4. This announcement contains certain forward looking statements with respect to the financial conditions, results of operations and businesses of Cranswick. These statements involve risk and uncertainty because they relate to events and depend upon circumstances that will occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFFALSIAFIF
Date   Source Headline
11th Mar 20257:05 amRNSDirectorship
5th Mar 20252:24 pmRNSTotal Voting Rights
3rd Mar 20253:27 pmRNSHolding(s) in Company
24th Feb 20254:54 pmRNSDirector/PDMR Shareholding
10th Feb 20252:51 pmRNSAdditional Listing
3rd Feb 202510:04 amRNSTotal Voting Rights
22nd Jan 20251:21 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSQ3 Trading Update and Acquisition of JSR Genetics
7th Jan 20254:02 pmRNSTotal Voting Rights
27th Dec 20247:00 amRNSDirector/PDMR Shareholding
11th Dec 20243:26 pmRNSHolding(s) in Company
3rd Dec 20249:53 amRNSTotal Voting Rights
26th Nov 20247:00 amRNSINTERIM RESULTS
13th Nov 202411:41 amRNSTotal Voting Rights
1st Oct 202412:46 pmRNSTotal Voting Rights
1st Oct 202412:43 pmRNSBlock Listing LTIP return
1st Oct 202412:41 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 202412:38 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHalf Year Trading Update
25th Sep 20243:19 pmRNSDirector/PDMR Shareholding
16th Sep 202411:56 amRNSHolding(s) in Company
16th Sep 202411:55 amRNSHolding(s) in Company
12th Aug 202412:15 pmRNSDirector/PDMR Shareholding
6th Aug 20244:20 pmRNSDirector/PDMR Shareholding
5th Aug 202412:18 pmRNSDirector/PDMR Shareholding
5th Aug 202412:16 pmRNSDirector/PDMR Shareholding
5th Aug 202412:15 pmRNSDirector/PDMR Shareholding
5th Aug 202412:11 pmRNSDirector/PDMR Shareholding
1st Aug 202410:52 amRNSTotal Voting Rights
29th Jul 20244:02 pmRNSAGM Statement
29th Jul 20247:00 amRNSFirst quarter trading statement
3rd Jun 20249:42 amRNSTotal Voting Rights
21st May 20247:00 amRNSPreliminary Results
15th May 20245:22 pmRNSDirector/PDMR Shareholding
2nd May 20249:26 amRNSTotal Voting Rights
2nd Apr 20241:55 pmRNSBlock listing Interim Review
2nd Apr 20241:54 pmRNSBlock listing Interim Review
2nd Apr 20241:50 pmRNSTotal Voting Rights
27th Mar 20249:58 amRNSDirector/PDMR Shareholding
21st Mar 20241:57 pmRNSDirector/PDMR Shareholding
21st Mar 20241:55 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirectorate Change
15th Mar 20243:58 pmRNSDirector/PDMR Shareholding
4th Mar 20249:58 amRNSTotal Voting Rights
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
14th Feb 202410:11 amRNSDirector/PDMR Shareholding
2nd Feb 202411:00 amRNSTotal Voting Rights
18th Jan 20247:00 amRNSThird quarter trading statement
3rd Jan 20247:00 amRNSDirector/PDMR Shareholding
2nd Jan 20243:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.